IDH Inhibitors Offer New, Safer Option for Some Brain Tumors

Описание: IDH inhibitors are now approved by the Food and Drug Administration (FDA) and are available for patients with lower-grade gliomas, offering a therapeutic option with a more manageable side effect profile compared with traditional chemotherapy, according to Dr. Ryan Merrell.

In an interview with CURE, in tandem with Brain Tumor Awareness Month, Merrell also encouraged patients with glioblastoma to consider clinical trials, noting that while many studies haven’t met their primary goals, some patients see meaningful benefit. “You could be that person,” he said.

Merrell is the division chief of neuro-oncology and associate professor of neurology at Vanderbilt University Medical Center.

View more at http://curetoday.com/

Or visit our socials!

CURE has become the largest consumer magazine in the United States, focusing entirely on cancer. With a total circulation of 285,000, individual subscribers account for over 140,000 of that figure, with the remainder including cancer centers and advocacy groups around the country. CURE’s time-tested approach combines science, humanity and technology to make cancer understandable for patients and their caregivers.